poisar

Filings · News reference

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting On August 18, 2026; Issues 165,000 Shares As Consideration For Asset Purchase

BenzingaAug 19, 2026, 9:21 PMBenzinga Newsdesk

-SEC Filing

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 19, 2026, 9:21 PM
Checked
Aug 19, 2026, 9:21 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading